Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Yuki Abe, Masaru Suzuki, Hiroshi Shima, Yusuke Shiraishi, Naoya Tanabe, Susumu Sato, Kaoruko Shimizu, Hirokazu Kimura, Hironi Makita, Toyohiro Hirai, Satoshi Konno & Masaharu Nishimura. (2021) Annual Body Weight Change and Prognosis in Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3243-3253.
Read now
Read now
Hironi Makita, Masaru Suzuki, Satoshi Konno, Kaoruko Shimizu, Yasuyuki Nasuhara, Katsura Nagai, Yasushi Akiyama, Satoshi Fuke, Hiroshi Saito, Takeshi Igarashi, Kimihiro Takeyabu & Masaharu Nishimura. (2020) Unique Mortality Profile in Japanese Patients with COPD: An Analysis from the Hokkaido COPD Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2081-2090.
Read now
Read now
Masakazu Ichinose, Yasushi Fukushima, Yoshikazu Inoue, Osamu Hataji, Gary T Ferguson, Klaus F Rabe, Nobuya Hayashi, Hiroshi Okada, Mami Takikawa, Eric Bourne, Shaila Ballal, Kiernan DeAngelis, Magnus Aurivillius, Paul Dorinsky & Colin Reisner. (2019) Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2979-2991.
Read now
Read now
Ryosuke Hirano, Masaki Fujita, Takemasa Matsumoto, Rintaro On & Kentaro Watanabe. (2018) Inhaled corticosteroids might not increase the risk of pneumonia in patients with chronic obstructive pulmonary disease in Japan. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3503-3509.
Read now
Read now
Masakazu Ichinose, Masaharu Nishimura, Manabu Akimoto, Yasuhiro Kurotori, Yihua Zhao, Alberto de la Hoz & Michiaki Mishima. (2018) Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2147-2156.
Read now
Read now
Ataru Igarashi, Yoshinosuke Fukuchi, Kazuto Hirata, Masakazu Ichinose, Atsushi Nagai, Masaharu Nishimura, Hajime Yoshisue, Kenichi Ohara & Jean-Bernard Gruenberger. (2018) COPD uncovered: a cross-sectional study to assess the socioeconomic burden of COPD in Japan. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2629-2641.
Read now
Read now
Articles from other publishers (20)
Akira Koarai, Mitsuhiro Yamada, Tomohiro Ichikawa, Naoya Fujino, Tomotaka Kawayama & Hisatoshi Sugiura. (2022) Triple versus LAMA/LABA combination therapy for Japanese patients with COPD: A systematic review and meta-analysis. Respiratory Investigation 60:1, pages 90-98.
Crossref
Crossref
Hitomi Ajimizu, Hiroaki Ozasa, Susumu Sato, Tomoko Funazo, Yuichi Sakamori, Takashi Nomizo, Kiyomitsu Kuninaga, Tatsuya Ogimoto, Kazutaka Hosoya, Masatoshi Yamazoe, Takahiro Tsuji, Hironori Yoshida, Ryo Itotani, Kentaro Ueno, Young Hak Kim, Shigeo Muro & Toyohiro Hirai. (2021) Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer. Scientific Reports 11:1.
Crossref
Crossref
Shigeo Muro, Masaru Suzuki, Shuhei Nakamura, Jocelyn Ruoyi Wang, Elizabeth M. Garry, Wataru Sakamoto & Sabrina de Souza. (2021) Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score–matched cohort analysis. Respiratory Research 22:1.
Crossref
Crossref
Yuki Abe, Masaru Suzuki, Hironi Makita, Hirokazu Kimura, Kaoruko Shimizu, Satoshi Konno & Masaharu Nishimura. (2021) One‐year clinically important deterioration and long‐term clinical course in Japanese patients with COPD: a multicenter observational cohort study. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Shih-Lung Cheng. (2021) Comparison of Effectiveness Using Different Dual Bronchodilator Agents in Chronic Obstructive Pulmonary Disease Treatment. Journal of Clinical Medicine 10:12, pages 2649.
Crossref
Crossref
David M. G. Halpin, Gerard J. Criner, Mark T. Dransfield, MeiLan K. Han, Benjamin Hartley, Catherine Harvey, C. Elaine Jones, Motokazu Kato, Peter Lange, Sally Lettis, David A. Lomas, Fernando J. Martinez, Neil Martin, Dave Singh, Robert Wise, Jinping Zheng & David A. Lipson. (2020) Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT Trial. Pulmonary Therapy 7:1, pages 101-118.
Crossref
Crossref
Yasuhiro Gon, Koichi Nishi, Kazuhiro Sato, Andrea Maes, Shahid Siddiqui, Nobuya Hayashi, Hajime Hirata, Ubaldo J. Martin & Colin Reisner. (2021) Efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler delivered using co-suspension delivery technology in Japanese patients with moderate-to-very severe chronic obstructive pulmonary disease. Respiratory Investigation 59:1, pages 135-144.
Crossref
Crossref
Zhenlei Wang, Yusuke Tadayasu, Na Hu, Shiqing Shu, Chao Hu & Zhu Luo. (2020) Pharmacokinetics and safety of tiotropium+olodaterol 5 μg/5 μg fixed-dose combination in Chinese patients with COPD. Pulmonary Pharmacology & Therapeutics 63, pages 101944.
Crossref
Crossref
Jie He & Jiang-Tao Lin. (2020) A comparison of tiotropium/olodaterol vs tiotropium alone in terms of treatment effect for chronic obstructive pulmonary disease. Medicine 99:16, pages e19789.
Crossref
Crossref
Hannah A. Blair. (2019) Tiotropium/Olodaterol: A Review in COPD. Drugs 79:9, pages 997-1008.
Crossref
Crossref
Usman Maqsood, Terence N Ho, Karen Palmer, Fiona JR Eccles, Mohammed Munavvar, Ran Wang, Iain Crossingham & David JW Evans. (2019) Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2019:3.
Crossref
Crossref
Chin Kook Rhee, Hajime Yoshisue & Rahul Lad. (2019) Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives. Advances in Therapy 36:3, pages 495-519.
Crossref
Crossref
Eric Derom, Guy G. Brusselle & Guy F. Joos. (2019) The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects. Therapeutic Advances in Respiratory Disease 13, pages 175346661984342.
Crossref
Crossref
Marc Miravitlles, Seungjae BaekVatsal VithlaniRahul Lad. (2018)
Optimal Bronchodilation for COPD Patients: Are All Long-Acting β
2
-Agonist/Long-Acting Muscarinic Antagonists the Same?
. Tuberculosis and Respiratory Diseases 81:3, pages 198.
Crossref
Crossref
Hiroyoshi Machida, Yoko Shibata, Sumito Inoue, Akira Igarashi, Yoshikane Tokairin, Keiko Yamauchi, Tomomi Kimura, Kento Sato, Hiroshi Nakano, Michiko Nishiwaki, Maki Kobayashi, Sujeong Yang, Yukihiro Minegishi, Kodai Furuyama, Tomoka Yamamoto, Tetsu Watanabe, Tsuneo Konta, Yoshiyuki Ueno, Takeo Kato, Takamasa Kayama & Isao Kubota. (2018) Prevalence of diabetes mellitus in individuals with airflow obstruction in a Japanese general population: The Yamagata-Takahata Study. Respiratory Investigation 56:1, pages 34-39.
Crossref
Crossref
Masakazu Ichinose, Yoshiaki Minakata, Takashi Motegi, Jun Ueki, Tetsuo Seki, Tatsuhiko Anzai, Ayako Takizawa, Lars Grönke & Kazuto Hirata. (2017) Study Design of VESUTO®: Efficacy of Tiotropium/Olodaterol on Lung Hyperinflation, Exercise Capacity, and Physical Activity in Japanese Patients with Chronic Obstructive Pulmonary Disease. Advances in Therapy 34:7, pages 1622-1635.
Crossref
Crossref
Hiroyuki Ohbayashi, Sahori Kudo & Masatake Ishikawa. (2017) Inhaler Operability and Patient Satisfaction Regarding Genuair® and Respimat® Inhalers for Chronic Obstructive Pulmonary Disease: A Randomized Crossover Study. Pulmonary Therapy 3:1, pages 173-185.
Crossref
Crossref
Masakazu Ichinose, Motokazu Kato, Ayako Takizawa, Wataru Sakamoto, Lars Grönke, Kay Tetzlaff & Yoshinosuke Fukuchi. (2017) Long-term safety and efficacy of combined tiotropium and olodaterol in Japanese patients with chronic obstructive pulmonary disease. Respiratory Investigation 55:2, pages 121-129.
Crossref
Crossref
Toshio Nakaki. 2017. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
133
144
.
Masaharu Nishimura. (2016) Similarities and differences between East and West in COPD. Respirology 21:8, pages 1340-1341.
Crossref
Crossref